McAndrews Secures TTAB Victory for Client AbbVie
01.28.19
McAndrews shareholders Patrick J. Arnold and Edward A. Mas II secured dismissal of an opposition proceeding in a trademark opposition before the Trademark Trial and Appeal Board (TTAB) for client AbbVie Biotechnology Ltd.
The opposition was brought by Novartis AG, and it involved AbbVie’s application to register SKYRIZI. Click here to view opinion.